David Kestenbaum

Chief Financial Officer
XTL Biopharmaceuticals
Israel

Business Expert General Science
Biography

 David Kestenbaum has served as Chief Financial Officer in our Company since January 2014. Previously, from 2010 to 2012, he served as CFO of Zenith Solar Ltd., a start-up company involved in the development and deployment of innovative solar energy technology. Prior positions include Finance Director of Colbar Lifescience Ltd., a medical device/biotech company and division of Johnson and Johnson (NYSE:JNJ) from 2007 to 2010, CFO of ZAG Industries Ltd., a division of The Stanleyworks (NYSE:SWK) from 2003 to 2007, and CFO and other senior financial positions at affiliates of Unilever NV (NYSE: UN) in the US and Israel. Before entering the industry, he worked in public accounting at PriceWaterhouseCoopers in NY from 1986 to 1990. Mr. Kestenbaum is a US Certified Public Accountant and holds a BSc in Accounting from Yeshiva University (NY), and a MBA in Finance and International Business from Columbia University (NY).

Research Intrest

 Lifescience

Global Scientific Words in General Science